FAST NEWS: CanSino’s Inhaled Covid Booster Gets China Green Light
The latest: CanSino Biologics Inc. (6185.HK; 688185.SH) announced on Sunday that China’s National Medical Products Administration (NMPA) have given emergency use authorization for its inhaled recombinant Covid-19 vaccine for use as…
RELATED ARTICLES
-
Fosun Pharma, CanSino take different paths as Covid lift fade
2196.HK 6185.HK
-
With healthier finances, Clover Bio shifts to flu and RSV vaccines
2197.HK
- Health Guard plans dual listing to fund HPV vaccine fight
-
FAST NEWS: CanSino’s revenue plunges as demand dries up for Covid vaccines
6185.HK 688185.SHG
-
FAST NEWS: CanSino receives Gates Foundation grant to develop polio vaccine
6185.HK 688185.SHG
- China’s mRNA pioneer Stemirna faces post-Covid reinvention test
Discover hidden China stock gems in our weekly newsletter